北京大学学报(医学版) ›› 2019, Vol. 51 ›› Issue (1): 171-176. doi: 10.19723/j.issn.1671-167X.2019.01.029

• 论著 • 上一篇    下一篇

上消化道固有肌层肿瘤经内镜黏膜下隧道肿瘤切除术和黏膜下肿瘤挖除术的治疗对比

田雪丽,黄永辉(),姚炜,李渊,陆京京   

  1. 北京大学第三医院消化科, 北京 100191
  • 收稿日期:2018-07-25 出版日期:2019-02-18 发布日期:2019-02-26
  • 通讯作者: 黄永辉 E-mail:huangyonghui@medmail.com.cn
  • 基金资助:
    国家自然科学基金(81470905)

Comparative treatment analysis of upper gastroenterology submucosal tumors originating from muscularis propria layer: submucosal tunneling endoscopic resection versus endoscopic submucosal excavation

Xue-li TIAN,Yong-hui HUANG(),Wei YAO,Yuan LI,Jing-jing LU   

  1. Department of Gastroenterology, Peking University Third Hospital, Beijing 100191, China
  • Received:2018-07-25 Online:2019-02-18 Published:2019-02-26
  • Contact: Yong-hui HUANG E-mail:huangyonghui@medmail.com.cn
  • Supported by:
    Supported by the National Natural Science Foundation of China(81470905)

摘要:

目的:评价内镜经黏膜下隧道肿瘤切除术(submucosal tunneling endoscopic resection,STER)和黏膜下肿瘤挖除术(endoscopic submucosal excavation,ESE)治疗上消化道固有肌层肿瘤的疗效和安全性。方法:选择2013 年4 月至2016 年12 月在北京大学第三医院诊断为上消化道固有肌层肿瘤并行STER治疗(n=28)和ESE治疗(n=14)的患者病例资料进行回顾分析,分析比较两组的临床病理和内镜结果、治疗和并发症发生情况。结果:42 例病变均顺利完成切除,成功率100%。两组间(STER组 vs. ESE组)从性别、年龄、病变大小[1.5(1.0~6.0) cm vs. 1.3(0.5~2.0) cm,P=0.056]差异均无统计学意义,STER组的病变切除时间长于ESE组[46.5(11.0~163.0) min vs. 19.5(6.0~56.0) min, P=0.007],创面钛夹缝合时间短于ESE组[3.5(1.0~11.0) min vs. 8.0(2.0~33.0) min, P=0.006],两组差异均有统计学意义,但总的手术时间的差异无统计学意义[52.0(14.0~167.0) min vs. 31.5(10.0~88.0) min,P=0.080]。术后一次性整块切除率(92.9% vs. 85.7%)、治疗后住院时间、术后并发症(10.7% vs. 0)两组间差异无统计学意义。STER组术后发生肺炎2 例,纵隔气肿1 例,保守对症支持治疗后痊愈;ESE组术后无并发症发生。术后经常规病理及免疫组化染色确诊平滑肌瘤28 例,间质瘤14 例。STER组6 例间质瘤均为极低危险度;ESE组4 例间质瘤为极低危险度,4例间质瘤为中等危险度[病变大小约1.0~2.0 cm,核分裂像(6~8)个/50 高倍视野]。所有患者中位随访时间46.5 个月(24~60个月),中等危险度间质瘤的患者最短随访时间为32个月,均未见肿瘤残留、复发及隧道内种植。结论:STER和ESE均可成为治疗来源于上消化道固有肌层的黏膜下肿瘤的有效、安全的方案选择之一,与STER相比,ESE切除病变时间短,但创面缝合时间长,总的手术时间相当。

关键词: 上消化道固有肌层肿瘤, 内镜, 对比研究, 内镜经黏膜下隧道肿瘤切除术, 内镜黏膜下肿瘤挖除术

Abstract:

Objective:To evaluate the efficacy and safety of submucosal tunneling endoscopic resection (STER) and endoscopic submucosal excavation (ESE) for upper gastroenterology submucosal tumors (SMT) originating from the muscularis propria (MP) layer. Methods: Clinicopathological and endoscopic data of 42 cases with upper gastroenterology tumors originating from the MP layer who were treated with STER (n=28) or ESE (n=14) between April 2013 and December 2016 in Peking University Third Hospital were retrospectively analyzed. The treatment and complications of the two groups were compared. Results: In the study, 42 cases were all resected by therapeutic endoscopy successfully.There was no significant difference (STER vs. ESE) in gender, age, mean tumor size [1.5 (1.0-6.0) cm vs. 1.3 (0.5-2.0) cm,P=0.056]. STER was superior to ESE with reduced sutured time [3.5 (1.0-11.0) min vs. 8.0 (2.0-33.0) min, P=0.006], but more resection time [46.5 (11.0-163.0) min vs.19.5 (6.0-56.0) min, P=0.007]. There was statistical difference between the two groups in resection time or sutured time, but no significant difference (STER vs. ESE) in total operative time [52.0 (14.0-167.0) min vs. 31.5 (10.0-88.0) min, P=0.080]. En bloc resection rates (92.9% vs. 85.7%), hospital stay duration and complications (10.7 vs. 0.0) were similar in the STER and ESE groups. One case developed mediastinal emphysema and 2 pneumonia after operation in STER group, and all of them recovered uneventfully after conservative treatments; There were no complications in the ESE group. After operation, 28 cases of leiomyoma and 14 cases of stromal tumor were diagnosed by routine pathological and immunohistochemical staining. Among them, 6 cases of stromal tumors in group STER were all extremely low risk, 4 cases of stromal tumors in group ESE were extremely low risk, 4 cases of stromal tumors in group ESE were medium risk (the size of the lesion was about 1.0-2.0 cm, and mitotic figures counted (6-8)/50 high power field). The median follow-up time of all the patients was 46.5 (24-60) months, and the shortest follow-up time for medium risk stromal tumors was 32 months. No residual tumor, recurrence and implantation in the tunnel were observed. Conclusion: STER or ESE can be used as an effective and safe option for treatment of submucosal tumors originating from the muscularis propria of the upper digestive tract. Compared with STER, ESE had shorter resection time but longer wound closure time. There was no significant difference in total operation time.

Key words: Upper gastroenterology submucosal neoplasms, Endoscopes, Comparative study, Submucosal tunneling endoscopic resection, Endoscopic submucosal excavation

中图分类号: 

  • R735

图1

内镜经黏膜下肿瘤挖除术"

图2

内镜经黏膜下隧道肿瘤切除术"

表1

STER组和ESE组患者基线特征分析"

Items STER (n=28) ESE (n=14) P value
Patients 27 14 -
Gender, n (%)
Male 11 (40.7) 6 (42.9) 1.000
Female 16 (59.3) 8 (57.1)
Age/years, x?±s 50.1 (9.7) 56.3 (14.3) 0.105
Tumor size/cm, median (range) 1.5 (1.0-6.0) 1.3 (0.5-2.0) 0.056
Pathological diagnosis, n (%)
Leiomyoma 22 (78.6) 6 (42.9) 0.021
GIST 6 (21.4) 8 (57.1)

表2

STER和ESE两组治疗结果有效性分析"

Items STER (n=28) ESE (n=14) P value
Resection time/min, median(range) 46.5 (11.0-163.0) 19.5 (6.0-56.0) 0.007
Suture time/min, median (range) 3.5 (1.0-11.0) 8.0 (2.0-33.0) 0.006
Total operation time/min, median (range) 52.0 (14.0-167.0) 31.5 (10.0-88.0) 0.080
En bloc resection, n (%) 26 (92.9) 12 (85.7) 0.457
Complete resection, n (%) 28 (100) 14 (100) -
Residual, n (%) 0 (0) 0 (0) -
Recurrence, n (%) 0 (0) 0 (0) -
Follow up-time/months, median (range) 49.5 (24-60) 43.5 (24-58) 0.126

表3

STER和ESE两组治疗安全性分析"

Items STER (n=28) ESE (n=14) P value
Complications, n (%) 3 (10.7) 0 (0) 0.539
Gas-related 1 (3.6) 0 -
Infection 2 (7.1) 0 -
Bleeding 0 0 -
Others 0 0 -
Hospital stay duration/d, median (range) 7 (4-15) 7 (5-11) 0.420
[1] 周平红, 姚礼庆, 徐美东 , 等. 消化道黏膜下肿瘤的内镜黏膜下挖除术治疗[J]. 中国医疗器械信息, 2008,14(10):3-5.
doi: 10.3969/j.issn.1006-6586.2008.10.002
[2] Xu MD, Cai MY, Zhou PH ,et a1. Submucosal tunneling endoscopic resection: a new technique for treating upper gastrointestinal submucosal tumors originating from the muscularis propria layer[J]. Gastrointest Endosc, 2012,75(1):195-199.
doi: 10.1016/j.gie.2011.08.018 pmid: 22056087
[3] Lu J, Jiao T, Zheng M , et al. Endoscopic resection of submucosal tumors in muscularis propria: the choice between direct excavation and tunneling resection[J]. Surg Endosc, 2014,28(12):3401-3407.
doi: 10.1007/s00464-014-3610-y pmid: 24986008
[4] 李江虹, 刘枫施, 施新岗 , 等. 内镜黏膜下肿物挖除术及内镜经黏膜下隧道肿瘤切除术治疗胃食管连接处固有肌层肿瘤的对比分析[J]. 中华消化内镜杂志, 2017,34(3):173-176.
doi: 10.3760/cma.j.issn.1007-5232.2017.03.006
[5] Du C, Chai N, Linghu E , et al. Treatment of cardial submucosal tumors originating from the muscularis propria layer: submucosal tunneling endoscopic resection versus endoscopic submucosal excavation[J]. Surg Endosc, 2018,32(11):4543-4551.
doi: 10.1007/s00464-018-6206-0 pmid: 29766300
[6] Koo DH, Ryu MH, Kim KM . Asian consensus guidelines for the diagnosis and management of gastrointestinal stromal tumor[J]. Cancer Res Treat, 2016,48(4):1155-1166.
doi: 10.4143/crt.2016.187 pmid: 27384163
[7] Koga T, Hirayama Y, Yoshiya S , et al. Necessity for resection of gastric gastrointestinal stromal tumors </= 20mm[J]. Anticancer Res, 2015,35(4):2341-2344.
[8] Abe N, Takeuchi H, Ohki A , et al. Comparison between endoscopic and laparoscopic removal of gastric submucosal tumor[J]. Dig Endosc, 2018,30(Suppl 1):7-16.
doi: 10.1111/den.2018.30.issue-S1
[9] Goto O, Takeuchi H, Kitagawa Y , et al. Endoscopic submucosal dissection (ESD) and related rechniques as precursors of “new notes” resection methods for gastric neoplasms[J]. Gastrointest Endosc Clin N Am, 2016,26(2):313-322.
doi: 10.1016/j.giec.2015.12.006 pmid: 27036900
[10] Chen T, Lin ZW, Zhang YQ , et al. Submucosal tunneling endoscopic resection vs. thoracoscopic enucleation for large submucosal tumors in the esophagus and the esophagogastric junction[J]. J Am Coll Surg, 2017,225(6):806-816.
doi: 10.1016/j.jamcollsurg.2017.09.002 pmid: 28923691
[11] Zhang Y, Ye LP, Mao XL . Endoscopic treatments for small gastric subepithelial tumors originating from muscularis propria layer[J]. World J Gastroenterol, 2015,21(32):9503-9511.
doi: 10.3748/wjg.v21.i32.9503 pmid: 26327758
[12] Wong VWY, Goto O, Gregersen H , et al. Endoscopic treatment of subepithelial lesions of the gastrointestinal tract[J]. Curr Treat Options Gastroenterol, 2017,15(4):603-617.
doi: 10.1007/s11938-017-0152-0 pmid: 29030800
[13] Al-Bawardy B, Rajan E, Wong Kee Song LM . Over-the-scope clip-assisted endoscopic full-thickness resection of epithelial and subepithelial GI lesions[J]. Gastrointest Endosc, 2017,85(5):1087-1092.
doi: 10.1016/j.gie.2016.08.019 pmid: 27569858
[14] Fernández JÁ, Gómez-Ruiz ÁJ, Olivares V , et al. Clinical and pathological features of “small” GIST (≤2 cm). What is their prognostic value[J]. Eur J Surg Oncol, 2018,44(5):580-586.
doi: 10.1016/j.ejso.2018.01.087 pmid: 29478742
[1] 牛占岳,薛艳,张静,张贺军,丁士刚. 胃腺瘤性息肉的内镜和病理特点及癌变的危险因素分析[J]. 北京大学学报(医学版), 2021, 53(6): 1122-1127.
[2] 越雷,王月田,白纯碧,陈浩,付豪永,于峥嵘,李淳德,孙浩林. 内镜治疗中青年双节段腰椎间盘突出症患者的手术策略[J]. 北京大学学报(医学版), 2021, 53(4): 734-739.
[3] 王迎春,黄永辉,常虹,姚炜,闫秀娥,李柯,张耀鹏,郑炜. 十二指肠乳头息肉良、恶性病变比较及活检准确性[J]. 北京大学学报(医学版), 2021, 53(1): 204-209.
[4] 武颖超,蔡云龙,戎龙,张继新,刘金,汪欣. 早期胃癌淋巴结转移规律及内镜黏膜下剥离术治疗早期胃癌的疗效评价[J]. 北京大学学报(医学版), 2020, 52(6): 1093-1097.
[5] 康宁,蒋一航,蒋宇光,吴栗洋,张际青,牛亦农,张军晖. 内镜联合超声与单纯超声引导建立皮肾通道在多镜联合术中的应用[J]. 北京大学学报(医学版), 2020, 52(4): 692-696.
[6] 张军晖,蒋一航,蒋宇光,张际青,康宁. 双侧同步内镜手术治疗双侧上尿路结石的临床效果[J]. 北京大学学报(医学版), 2020, 52(4): 672-677.
[7] 李潇,苏家增,张严妍,张丽琪,张亚琼,柳登高,俞光岩. 131I相关唾液腺炎的炎症分级及内镜治疗[J]. 北京大学学报(医学版), 2020, 52(3): 586-590.
[8] 刘鑫,张静,王晔,张贺军,丁士刚,周丽雅. 早期胃癌白光内镜下特征分析[J]. 北京大学学报(医学版), 2019, 51(2): 302-306.
[9] 修倩,陈曦, 刘潼,陈明星,姚平,辛伟红. 气管切开后再次出现呼吸困难2例及Mimics 10.01软件的临床应用[J]. 北京大学学报(医学版), 2018, 50(5): 924-927.
[10] 李士杰,王警,李子禹,步召德,苏向前,李忠武,吴齐. 内镜黏膜下剥离术在早期胃癌治疗中的应用[J]. 北京大学学报(医学版), 2015, 47(6): 945-951.
[11] 尹焯, 杨金瑞, 王钊, 魏永宝, 严彬, 周克勤. 阴囊镜在睾丸附睾疾病诊断与治疗中的应用[J]. 北京大学学报(医学版), 2015, 47(4): 648-652.
[12] 闫秀娥,王丽,周丽雅,林三仁,王晔,程志蓉. 171例食管上段异物的内镜治疗[J]. 北京大学学报(医学版), 2014, 46(1): 160-164.
[13] 蒋媛嫄, 王霄英, 郭雪梅, 蒋学祥. 磁共振成像与多排探测器CT对乙型肝炎肝硬化背景上小肝癌诊断价值的比较研究[J]. 北京大学学报(医学版), 2010, 42(6): 767-772.
[14] 宋志强, 顾芳, 姚炜, 李军, 周丽雅, 林三仁. 胶囊内镜在消化系统疾病中的诊断价值[J]. 北京大学学报(医学版), 2010, 42(5): 539-542.
[15] 孙建军, , 王振宇, 谢京城, 李振东, 马长城, 刘彬, 赵继宗. 多节段髓内先天性肿瘤和良性室管膜瘤的对比分析[J]. 北京大学学报(医学版), 2010, 42(2): 183-187.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 田增民, 陈涛, Nanbert ZHONG, 李志超, 尹丰, 刘爽. 神经干细胞移植治疗遗传性小脑萎缩的临床研究(英文稿)[J]. 北京大学学报(医学版), 2009, 41(4): 456 -458 .
[2] 成刚, 钱振华, 胡军. 艾滋病项目自愿咨询检测的技术效率分析[J]. 北京大学学报(医学版), 2009, 41(2): 135 -140 .
[3] 卢恬, 朱晓辉, 柳世庆, 郑杰, 邱晓彦. 白细胞介素2促进宫颈癌细胞系HeLaS3免疫球蛋白G的表达[J]. 北京大学学报(医学版), 2009, 41(2): 158 -161 .
[4] 袁惠燕, 张苑, 范田园. 离子交换型栓塞微球及其载平阳霉素的制备与性质研究[J]. 北京大学学报(医学版), 2009, 41(2): 217 -220 .
[5] 徐莉, 孟焕新, 张立, 陈智滨, 冯向辉, 释栋. 侵袭性牙周炎患者血清中抗牙龈卟啉单胞菌的IgG抗体水平的研究[J]. 北京大学学报(医学版), 2009, 41(1): 52 -55 .
[6] 董稳, 刘瑞昌, 刘克英, 关明, 杨旭东. 氯诺昔康和舒芬太尼用于颌面外科术后自控静脉镇痛的比较[J]. 北京大学学报(医学版), 2009, 41(1): 109 -111 .
[7] 祁琨, 邓芙蓉, 郭新彪. 纳米二氧化钛颗粒对人肺成纤维细胞缝隙连接通讯的影响[J]. 北京大学学报(医学版), 2009, 41(3): 297 -301 .
[8] Jian-wei GU, Emily YOUNG, Zhi-jun PAN, Kevan B. TUCKER, Megan SHPARAGO, Min HUANG, Amelia Purser BAILEY. SD大鼠长期高盐饮食可导致其高血压并改变肾细胞因子基因表达谱[J]. 北京大学学报(医学版), 2009, 41(5): 505 -515 .
[9] 李宏亮*, 安卫红*, 赵扬玉, 朱曦. 妊娠合并高脂血症性胰腺炎行血液净化治疗1例[J]. 北京大学学报(医学版), 2009, 41(5): 599 -601 .
[10] 李伟军, 邢晓芳, 曲立科, 孟麟, 寿成超. PRL-3基因C104S位点突变体和CAAX缺失体的构建及表达[J]. 北京大学学报(医学版), 2009, 41(5): 516 -520 .